A UK-based company raised money that will help them develop medicines with low-dose psilocybin to treat patients with rare headaches and a severe type of depression. Beckley Psytech, of Oxford, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, has announced that it secured £58m to fund […] The post UK company to develop psychedelic medicines for patients with depression and headaches appeared first on Canex.
Excerpt only …
READ MORE BELOW
Source : UK company to develop psychedelic medicines for patients with depression and headaches
reposted by Cannabis News World